Serum bactericidal activity of ceftazidime administered as continuous infusion of 3 g over 24 h versus intermittent bolus infusion of 2 g against Pseudomonas aeruginosa in healthy volunteers [5]

Journal of Antimicrobial Chemotherapy

Volumn 39, Issue 6, 1997, Pages 841-842

  Lemmen, S W ^a   Engels, I ^a   Daschner, F D ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CEFTAZIDIME;

BOLUS INJECTION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTINUOUS INFUSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOSE TIME EFFECT RELATION; GRAM NEGATIVE INFECTION; HUMAN; HUMAN EXPERIMENT; INTRAVENOUS DRUG ADMINISTRATION; LETTER; MINIMUM INHIBITORY CONCENTRATION; NORMAL HUMAN; POSTANTIBIOTIC EFFECT; PSEUDOMONAS AERUGINOSA; RANDOMIZED CONTROLLED TRIAL; SERUM BACTERICIDAL ACTIVITY;

CEFTAZIDIME; CEPHALOSPORINS; HUMANS; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; SERUM BACTERICIDAL TEST;

EID: 0030876084     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (6)